Roderick E. Hubbard
Affiliations: | Chemistry | University of York (UK) |
Google:
"Roderick Hubbard"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Vagrys D, Davidson J, Chen I, et al. (2020) Exploring IDP-Ligand Interactions: tau K18 as A Test Case. International Journal of Molecular Sciences. 21 |
| O'Brien P, Downes TD, Jones SP, et al. (2020) Design and Synthesis of 56 Shape Diverse 3-D Fragments. Chemistry (Weinheim An Der Bergstrasse, Germany) |
| Darby JF, Hopkins AP, Shimizu S, et al. (2019) Water networks can determine the affinity of ligand binding to proteins. Journal of the American Chemical Society |
| Szlávik Z, Ondi L, Csékei M, et al. (2019) Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity. Journal of Medicinal Chemistry |
| Raingeval C, Cala O, Brion B, et al. (2019) 1D NMR WaterLOGSY as an efficient method for fragment-based lead discovery. Journal of Enzyme Inhibition and Medicinal Chemistry. 34: 1218-1225 |
| Rachman MM, Barril X, Hubbard RE. (2018) Predicting how drug molecules bind to their protein targets. Current Opinion in Pharmacology. 42: 34-39 |
| Lamoree B, Hubbard RE. (2017) Current perspectives in fragment-based lead discovery (FBLD). Essays in Biochemistry. 61: 453-464 |
| Williamson DS, Smith GP, Acheson-Dossang P, et al. (2017) Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1). Journal of Medicinal Chemistry |
| Ruiz-Carmona S, Schmidtke P, Luque FJ, et al. (2017) Dynamic undocking and the quasi-bound state as tools for drug discovery. Nature Chemistry. 9: 201-206 |
| Renaud JP, Chung CW, Danielson UH, et al. (2016) Biophysics in drug discovery: impact, challenges and opportunities. Nature Reviews. Drug Discovery |